SHCBP1 drives tumor progression in triple-negative breast cancer

SHCBP1 drives tumor progression in triple-negative breast cancer

BackgroundsTriple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype. The limited treatment options underscore the urgent need to explore novel molecular targets to combat TNBC progression. This study investigates the oncogenic functions of SHCBP1 in TNBC.Materials an...

Full description

Saved in:
Bibliographic Details
Main Authors: Huiling Wang, Huijuan Dai, Liheng Zhou, Yanping Lin, Wenjin Yin, Jingsong Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Oncology
Subjects:
SHCBP1
single-cell RNA-seq
triple negative breast cancer
proliferation
migration
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1587236/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items